[Exosome separation and analysis based on microfluidics technology and its clinical applications].

Yu-Hang Xing, Xiang-Shan Ren, Dong-Hao Li, Lu Liu
{"title":"[Exosome separation and analysis based on microfluidics technology and its clinical applications].","authors":"Yu-Hang Xing, Xiang-Shan Ren, Dong-Hao Li, Lu Liu","doi":"10.3724/SP.J.1123.2024.10032","DOIUrl":null,"url":null,"abstract":"<p><p>Exosomes are cell-secreted nanoscale vesicles 30-150 nm in size and encompass a diverse array of biomolecules, including lipids, proteins, and nucleic acids. Exosomes play pivotal roles during the intercellular exchange of materials and information, and are closely associated with the onset and progression of a variety of diseases. Therefore, comprehensively investigating exosomes is very important in terms of disease diagnosis and treatment. However, exosomes are genetically heterogeneous and are composed of different materials. Additionally, exosome-size and packing-specific-biomarker heterogeneities result in biofunction diversity. Moreover, isolating and analyzing exosomes is highly challenging owing to their small sizes and heterogeneities. Accordingly, effective separation methods and analytical techniques for highly specifically and efficiently identifying exosomes are urgently needed in order to better understand their functionalities. While separation and analysis is required to reveal exosome heterogeneity, the former is confronted by three primary challenges. Firstly, exosome heterogeneity (including heterogeneous marker expressions and size heterogeneity that results in heterogeneous functions) results in systems that are very difficult to separate. Secondly, the coexistence of non-vesicular contaminants (lipoprotein nanoparticles, soluble proteins, nucleic acids, etc.) and the complex matrix effects of body fluids also contribute to separation difficulties. Thirdly, enrichment is a highly challenging task owing to low exosome concentrations. Traditional methods, such as ultracentrifugation and size-exclusion chromatography, fall short in terms of their abilities to precisely separate and analyze exosomes. On the other hand, microfluidics has emerged as a robust tool for the efficient analysis of complex biological samples and is characterized by miniaturization, precise control, high throughput, automation, and integration. Firstly, the operability, integrability, and modifiability of a microfluidics system facilitate exosome separation and purification based on surface properties, size, charge, and polarity. Secondly, the use of a microfluidics approach, with its high throughput, low reagent consumption, and multichannel manipulability, greatly facilitates preparing exosomes and enhancing their concentrations. Thirdly, microfluidics ensures that diverse separation methods are compatible with downstream analysis techniques. Exosomes are highly heterogeneous; hence, they are classified by type and subpopulation (according to origin, size, molecular markers, functions, etc.). This paper first discusses microfluidics techniques for separating exosomes and examines various separation strategies grounded in the physicochemical properties of exosomes. We then analyze exosome detection methodologies that use microfluidics platforms and encompass traditional group-exosome analysis techniques and novel single-exosome analysis approaches. Finally, we discuss future clinical applications of microfluidics technology in exosome research, particularly its potential for diagnosing and treating diseases, thereby underscoring the applications value of microfluidics technology in the realm of personalized and precision medicine. Furthermore, cutting-edge microfluidics platforms offer novel perspectives for purifying and preparing EVs owing to precise fluid control, integration, miniaturization, and high-throughput characterization. EV populations, subpopulations, and single vesicles can be purified based on their physicochemical properties and microfluidics features. Comprehensive lab-on-a-chip methods are promising in terms of separating EVs based on traits, such as size, surface markers, and charge, and for obtaining highly pure EVs. Recycled EV samples can be prepared by controlling the high-throughput and multichannel capabilities of microfluidics approaches. The transition from bulk EV analysis to single-vesicle analysis provides opportunities to explore the heterogeneous nature of EVs, thereby augmenting their potential for disease diagnosis.</p>","PeriodicalId":101336,"journal":{"name":"Se pu = Chinese journal of chromatography","volume":"43 5","pages":"455-471"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059995/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Se pu = Chinese journal of chromatography","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3724/SP.J.1123.2024.10032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Exosomes are cell-secreted nanoscale vesicles 30-150 nm in size and encompass a diverse array of biomolecules, including lipids, proteins, and nucleic acids. Exosomes play pivotal roles during the intercellular exchange of materials and information, and are closely associated with the onset and progression of a variety of diseases. Therefore, comprehensively investigating exosomes is very important in terms of disease diagnosis and treatment. However, exosomes are genetically heterogeneous and are composed of different materials. Additionally, exosome-size and packing-specific-biomarker heterogeneities result in biofunction diversity. Moreover, isolating and analyzing exosomes is highly challenging owing to their small sizes and heterogeneities. Accordingly, effective separation methods and analytical techniques for highly specifically and efficiently identifying exosomes are urgently needed in order to better understand their functionalities. While separation and analysis is required to reveal exosome heterogeneity, the former is confronted by three primary challenges. Firstly, exosome heterogeneity (including heterogeneous marker expressions and size heterogeneity that results in heterogeneous functions) results in systems that are very difficult to separate. Secondly, the coexistence of non-vesicular contaminants (lipoprotein nanoparticles, soluble proteins, nucleic acids, etc.) and the complex matrix effects of body fluids also contribute to separation difficulties. Thirdly, enrichment is a highly challenging task owing to low exosome concentrations. Traditional methods, such as ultracentrifugation and size-exclusion chromatography, fall short in terms of their abilities to precisely separate and analyze exosomes. On the other hand, microfluidics has emerged as a robust tool for the efficient analysis of complex biological samples and is characterized by miniaturization, precise control, high throughput, automation, and integration. Firstly, the operability, integrability, and modifiability of a microfluidics system facilitate exosome separation and purification based on surface properties, size, charge, and polarity. Secondly, the use of a microfluidics approach, with its high throughput, low reagent consumption, and multichannel manipulability, greatly facilitates preparing exosomes and enhancing their concentrations. Thirdly, microfluidics ensures that diverse separation methods are compatible with downstream analysis techniques. Exosomes are highly heterogeneous; hence, they are classified by type and subpopulation (according to origin, size, molecular markers, functions, etc.). This paper first discusses microfluidics techniques for separating exosomes and examines various separation strategies grounded in the physicochemical properties of exosomes. We then analyze exosome detection methodologies that use microfluidics platforms and encompass traditional group-exosome analysis techniques and novel single-exosome analysis approaches. Finally, we discuss future clinical applications of microfluidics technology in exosome research, particularly its potential for diagnosing and treating diseases, thereby underscoring the applications value of microfluidics technology in the realm of personalized and precision medicine. Furthermore, cutting-edge microfluidics platforms offer novel perspectives for purifying and preparing EVs owing to precise fluid control, integration, miniaturization, and high-throughput characterization. EV populations, subpopulations, and single vesicles can be purified based on their physicochemical properties and microfluidics features. Comprehensive lab-on-a-chip methods are promising in terms of separating EVs based on traits, such as size, surface markers, and charge, and for obtaining highly pure EVs. Recycled EV samples can be prepared by controlling the high-throughput and multichannel capabilities of microfluidics approaches. The transition from bulk EV analysis to single-vesicle analysis provides opportunities to explore the heterogeneous nature of EVs, thereby augmenting their potential for disease diagnosis.

Abstract Image

Abstract Image

Abstract Image

[基于微流体技术的外泌体分离分析及其临床应用]。
外泌体是细胞分泌的纳米级囊泡,大小为30- 150nm,包含多种生物分子,包括脂质、蛋白质和核酸。外泌体在细胞间物质和信息交换中起着关键作用,与多种疾病的发生和发展密切相关。因此,全面研究外泌体对疾病的诊断和治疗具有重要意义。然而,外泌体在遗传上是异质的,由不同的物质组成。此外,外泌体大小和包装特异性生物标志物异质性导致生物功能多样性。此外,由于外泌体的小尺寸和异质性,分离和分析外泌体极具挑战性。因此,迫切需要有效的分离方法和分析技术来高度特异性和高效地鉴定外泌体,以便更好地了解它们的功能。虽然需要分离和分析来揭示外泌体的异质性,但前者面临着三个主要挑战。首先,外泌体的异质性(包括异质标记表达和导致异质功能的大小异质性)导致系统很难分离。其次,非囊泡污染物(脂蛋白纳米颗粒、可溶性蛋白、核酸等)的共存以及体液的复杂基质效应也增加了分离的难度。第三,由于外泌体浓度低,富集是一项极具挑战性的任务。传统的方法,如超离心和尺寸排除色谱法,在精确分离和分析外泌体的能力方面存在不足。另一方面,微流体已经成为一种有效分析复杂生物样品的强大工具,具有小型化、精确控制、高通量、自动化和集成化的特点。首先,微流体系统的可操作性、可集成性和可修改性有助于基于表面性质、大小、电荷和极性的外泌体分离和纯化。其次,使用微流体方法,具有高通量,低试剂消耗和多通道可操作性,极大地促进了外泌体的制备和浓度的提高。第三,微流控确保了不同的分离方法与下游分析技术兼容。外泌体是高度异质性的;因此,它们被分类为类型和亚种群(根据起源、大小、分子标记、功能等)。本文首先讨论了分离外泌体的微流体技术,并根据外泌体的理化性质研究了各种分离策略。然后,我们分析了使用微流体平台的外泌体检测方法,包括传统的群外泌体分析技术和新颖的单外泌体分析方法。最后,我们讨论了微流体技术在外泌体研究中的未来临床应用,特别是其在疾病诊断和治疗方面的潜力,从而强调了微流体技术在个性化和精准医疗领域的应用价值。此外,由于精确的流体控制、集成、小型化和高通量表征,尖端的微流体平台为电动汽车的净化和制备提供了新的视角。EV种群、亚种群和单个囊泡可以根据它们的物理化学性质和微流体特性进行纯化。基于尺寸、表面标记物和电荷等特征来分离电动汽车,以及获得高纯度电动汽车,综合的芯片实验室方法是有前途的。回收EV样品可以通过控制微流体方法的高通量和多通道能力来制备。从整体EV分析到单囊泡分析的转变为探索EV的异质性提供了机会,从而增加了其疾病诊断的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信